Session 3: Diagnosis of HHT

08 Jun 2017
1:45 pm - 3:45 pm
Soderini Ballroom II, III

Session 3: Diagnosis of HHT

Invited Speaker:  Dr. Rosemary Akhurst  (1:45pm – 2:30pm)

Genetic Variants Modify TGFb/BMP Signaling and Clinical HHT Phenotypes

 

Oral Presentations

2:30pm – 2:45pm

Clinical, radiographic, and genetic findings of a cohort of 39 patients with hereditary hemorrhagic telangiectasia and brain vascular malformations

Kalani MYS, Joyce E, Eli I, Park, M, Taussky P, Schmidt R, McDonald J, Whitehead K

 

2:45pm – 3:00pm

Comparison of MRI and digital subtraction angiography for detection of cerebral arteriovenous malformations in hereditary hemorrhagic telangiectasia

Hetts S, Vella M, Alexander M, Mabray M, Dickey M

 

3:00pm – 3:15pm

Vitamin D levels are associated with decreased epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)

Weber LM, Whitehead K, McDonald J

 

3:15pm – 3:30pm

Screening children for pulmonary arteriovenous malformations: evaluation of 18

Hosman AE, de Gussem EM, Balemans W, Gauthier A, Westermann CJJ, Snijder RJ, Post M, Mager JJ

 

3:30pm – 3:45pm

Efficacy and safety of propranolol for epistaxis in hereditary hemorrhagic telangiectasia; retrospective, then prospective study, in a total of 21 patients

Contis A, Viallard JF, Goizet C, Duffau P